Clinical Trial Update: Study Of Ispinesib In Subjects With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports the results of ispinesib in subjects with breast cancer. The study has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ispinesib (ispinesib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2018-02-26